Terumo Corporation (TYO:4543)
Japan · Delayed Price · Currency is JPY 2,515.00
+23.50 (0.94%)
Nov 4, 2025, 3:30 PM JST
Terumo Revenue
Terumo had revenue of 259.97B JPY in the quarter ending June 30, 2025, with 0.69% growth. This brings the company's revenue in the last twelve months to 1.04T, up 7.58% year-over-year. In the fiscal year ending March 31, 2025, Terumo had annual revenue of 1.04T with 12.40% growth.
Revenue (ttm)
1.04T
Revenue Growth
+7.58%
P/S Ratio
3.54
Revenue / Employee
33.93M
Employees
30,591
Market Cap
3.68T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04T | 114.31B | 12.40% |
| Mar 31, 2024 | 921.86B | 101.65B | 12.39% |
| Mar 31, 2023 | 820.21B | 116.91B | 16.62% |
| Mar 31, 2022 | 703.30B | 89.46B | 14.57% |
| Mar 31, 2021 | 613.84B | -15.06B | -2.39% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Olympus | 969.02B |
| HOYA Corporation | 892.50B |
| Eisai | 803.02B |
Terumo News
- 4 days ago - OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation - GlobeNewsWire
- 6 days ago - Orchestra BioMed, Terumo Sign $30 Million Strategic Agreements For Virtue SAB - Nasdaq
- 2 months ago - Terumo Acquiring Its Way Into The Intriguing Organ Donation Market - Seeking Alpha
- 3 months ago - Terumo Corp (TRUMF) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - GuruFocus
- 3 months ago - Q1 2026 Terumo Corp Earnings Call Transcript - GuruFocus
- 3 months ago - Terumo Corporation (TRUMF) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Terumo: Consistent Execution Continues To Drive Solid Growth Metrics - Seeking Alpha
- 6 months ago - Terumo Corporation (TRUMF) Q4 2025 Earnings Call Transcript - Seeking Alpha